Interference by adrenaline with chondrogenic differentiation through suppression of gene transactivation mediated by Sox9 family members

Bone

Volumn 45, Issue 3, 2009, Pages 568-578

  Takarada, Takeshi ^a   Hojo, Hironori ^a   Iemata, Mika ^a   Sahara, Koichi ^a   Kodama, Ayumi ^a   Nakamura, Nobuhiro ^a   Hinoi, Eiichi ^a   Yoneda, Yukio ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Adrenaline; Beta receptor subtype; Chondrocytes; Fracture; Sox9 family

Indexed keywords

ADRENALIN; ALPHA 2A ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 2; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; MESSENGER RNA; PROPRANOLOL; TRANSCRIPTION FACTOR SOX9;

ANIMAL CELL; ARTICLE; BONE CELL; CALLUS; CARTILAGE CELL; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DOWN REGULATION; EMBRYO; ENZYME ACTIVATION; FEMUR FRACTURE; GENE ACTIVATION; GENE EXPRESSION REGULATION; METATARSAL BONE; MOUSE; NONHUMAN; PROTEIN FAMILY; SIGNAL TRANSDUCTION; TRANSACTIVATION;

ANIMALS; ANIMALS, NEWBORN; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; CYCLIC AMP; EMBRYO, MAMMALIAN; EPINEPHRINE; FRACTURES, BONE; METATARSAL BONES; MICE; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, ADRENERGIC, BETA-2; RNA, MESSENGER; SIGNAL TRANSDUCTION; SOX9 TRANSCRIPTION FACTOR; SOXD TRANSCRIPTION FACTORS; TIBIA; TRANSCRIPTIONAL ACTIVATION;

EID: 67949118774     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.05.004     Document Type: Article

References (32)

1. Karsenty G. The complexities of skeletal biology. Nature 423 (2003) 316-318
2. Kronenberg H.M. Developmental regulation of the growth plate. Nature 423 (2003) 332-336
3. Vortkamp A., Pathi S., Peretti G.M., Caruso E.M., Zaleske D.J., and Tabin C.J. Recapitulation of signals regulating embryonic bone formation during postnatal growth and in fracture repair. Mech. Dev. 71 (1998) 65-76
4. Deckelbaum R.A., Chan G., Miao D., Goltzman D., and Karaplis A.C. Ihh enhances differentiation of CFK-2 chondrocytic cells and antagonizes PTHrP-mediated activation of PKA. J. Cell. Sci. 115 (2002) 3015-3025
5. St-Jacques B., Hammerschmidt M., and McMahon A.P. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev. 13 (1999) 2072-2086
6. Takarada T., and Yoneda Y. Pharmacological topics of bone metabolism: glutamate as a signal mediator in bone. J. Pharmacol. Sci. 106 (2008) 536-541
7. Wang L., Hinoi E., Takemori A., Nakamichi N., and Yoneda Y. Glutamate inhibits chondral mineralization through apoptotic cell death mediated by retrograde operation of the cystine/glutamate antiporter. J. Biol. Chem. 281 (2006) 24553-24565
8. Nilsson O., Marino R., De Luca F., Phillip M., and Baron J. Endocrine regulation of the growth plate. Horm. Res. 64 (2005) 157-165
9. Elefteriou F., Ahn J.D., Takeda S., Starbuck M., Yang X., Liu X., Kondo H., Richards W.G., Bannon T.W., Noda M., Clement K., Vaisse C., and Karsenty G. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434 (2005) 514-520
10. Fu L., Patel M.S., Bradley A., Wagner E.F., and Karsenty G. The molecular clock mediates leptin-regulated bone formation. Cell 122 (2005) 803-815
11. Arai M., Nagasawa T., Koshihara Y., Yamamoto S., and Togari A. Effects of beta-adrenergic agonists on bone-resorbing activity in human osteoclast-like cells. Biochim. Biophys. Acta 1640 (2003) 137-142
12. Togari A. Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells. Microsc. Res. Tech. 58 (2002) 77-84
13. Lai L.P., and Mitchell J. Beta2-adrenergic receptors expressed on murine chondrocytes stimulate cellular growth and inhibit the expression of Indian hedgehog and collagen type X. J. Cell. Biochem. 104 (2008) 545-553
14. Malemud C.J., and Papay R.S. Stimulation of cyclic AMP in chondrocyte cultures: effects on sulfated-proteoglycan synthesis. FEBS Lett. 167 (1984) 343-351
15. Hein L. Adrenoceptors and signal transduction in neurons. Cell Tissue Res. 326 (2006) 541-551
16. Carson R.P., and Robertson D. Genetic manipulation of noradrenergic neurons. J. Pharmacol. Exp. Ther. 301 (2002) 410-417
17. Lefebvre V., Zhou G., Mukhopadhyay K., Smith C.N., Zhang Z., Eberspaecher H., et al. An 18-base-pair sequence in the mouse proalpha1(II) collagen gene is sufficient for expression in cartilage and binds nuclear proteins that are selectively expressed in chondrocytes. Mol. Cell. Biol. 16 (1996) 4512-4523
18. Bernard P., Tang P., Liu S., Dewing P., Harley V.R., and Vilain E. Dimerization of SOX9 is required for chondrogenesis, but not for sex determination. Hum. Mol. Genet. 12 (2003) 1755-1765
19. Takarada T., Hinoi E., Kambe Y., Sahara K., Kurokawa S., Takahata Y., et al. Osteoblast protects osteoclast devoid of sodium-dependent vitamin C transporters from oxidative cytotoxicity of ascorbic acid. Eur. J. Pharmacol. 575 (2007) 1-11
20. Takarada T., Hinoi E., Takahata Y., and Yoneda Y. Serine racemase suppresses chondrogenic differentiation in cartilage in a Sox9-dependent manner. J. Cell. Physiol. 215 (2008) 320-328
21. Hinoi E., Ueshima T., Hojo H., Iemata M., Takarada T., and Yoneda Y. Up-regulation of per mRNA expression by parathyroid hormone through a protein kinase A-CREB-dependent mechanism in chondrocytes. J. Biol. Chem. 281 (2006) 23632-23642
22. Bonnarens F., and Einhorn T.A. Production of a standard closed fracture in laboratory animal bone. J. Orthop. Res. 2 (1984) 97-101
23. Robson H., Siebler T., Stevens D.A., Shalet S.M., and Williams G.R. Thyroid hormone acts directly on growth plate chondrocytes to promote hypertrophic differentiation and inhibit clonal expansion and cell proliferation. Endocrinology 141 (2000) 3887-3897
24. Takeda S., Elefteriou F., Levasseur R., Liu X., Zhao L., Parker K.L., et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 111 (2002) 305-317
25. Price J.S., Oyajobi B.O., and Russell R.G. The cell biology of bone growth. Eur. J. Clin. Nutr. 48 Suppl 1 (1994) S131-S149
26. Foster J.W., Dominguez-Steglich M.A., Guioli S., Kowk G., Weller P.A., Stevanovic M., et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372 (1994) 525-530
27. Bi W., Huang W., Whitworth D.J., Deng J.M., Zhang Z., Behringer R.R., et al. Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 6698-6703
28. Akiyama H., Lyons J.P., Mori-Akiyama Y., Yang X., Zhang R., Zhang Z., et al. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev. 18 (2004) 1072-1087
29. Minkowitz B., Boskey A.L., Lane J.M., Pearlman H.S., and Vigorita V.J. Effects of propranolol on bone metabolism in the rat. J. Orthop. Res. 9 (1991) 869-875
30. Schlienger R.G., Kraenzlin M.E., Jick S.S., and Meier C.R. Use of beta-blockers and risk of fractures. JAMA 292 (2004) 1326-1332
31. Reid I.R., Gamble G.D., Grey A.B., Black D.M., Ensrud K.E., Browner W.S., et al. beta-Blocker use, BMD, and fractures in the study of osteoporotic fractures. J. Bone Miner. Res. 20 (2005) 613-618
32. Aspenberg P. Drugs and fracture repair. Acta Orthop. 76 (2005) 741-748